Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, Rapid Micro Biosystems Inc (NASDAQ: RPID) closed at $3.1 up 1.64% from its previous closing price of $3.05. In other words, the price has increased by $1.64 from its previous closing price. On the day, 50009.0 shares were traded. RPID stock price reached its highest trading level at $3.1331 during the session, while it also had its lowest trading level at $3.045.
Ratios:
For a deeper understanding of Rapid Micro Biosystems Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.95 and its Current Ratio is at 4.23. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.52.
Upgrades & Downgrades
In the most recent recommendation for this company, Lake Street on July 28, 2025, initiated with a Buy rating and assigned the stock a target price of $8.
On February 12, 2025, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 11 ’25 when Spignesi Robert G. Jr. sold 11,874 shares for $3.33 per share. The transaction valued at 39,499 led to the insider holds 957,286 shares of the business.
Spignesi Robert G. Jr. sold 11,881 shares of RPID for $39,481 on Jul 14 ’25. The PRESIDENT AND CEO now owns 970,550 shares after completing the transaction at $3.32 per share. On Jul 14 ’25, another insider, Spignesi Robert G. Jr., who serves as the Officer of the company, bought 11,881 shares for $3.32 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RPID now has a Market Capitalization of 137399920 and an Enterprise Value of 100731920. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.50 while its Price-to-Book (P/B) ratio in mrq is 3.10. Its current Enterprise Value per Revenue stands at 3.3 whereas that against EBITDA is -2.371.
Stock Price History:
The Beta on a monthly basis for RPID is 1.35, which has changed by 2.3479693 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, RPID has reached a high of $4.50, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is -11.70%, while the 200-Day Moving Average is calculated to be -1.30%.
Shares Statistics:
For the past three months, RPID has traded an average of 108.21K shares per day and 152600 over the past ten days. A total of 39.81M shares are outstanding, with a floating share count of 23.65M. Insiders hold about 46.68% of the company’s shares, while institutions hold 20.10% stake in the company. Shares short for RPID as of 1764288000 were 238781 with a Short Ratio of 1.49, compared to 1761868800 on 310680. Therefore, it implies a Short% of Shares Outstanding of 238781 and a Short% of Float of 1.8499999999999999.
Earnings Estimates
The market rating of Rapid Micro Biosystems Inc (RPID) is currently shaped by the ongoing analysis conducted by 3.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.21 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$1.0 and -$1.02 for the fiscal current year, implying an average EPS of -$1.01. EPS for the following year is -$0.86, with 4.0 analysts recommending between -$0.81 and -$0.91.
Revenue Estimates
A total of 4 analysts believe the company’s revenue will be $11.2M this quarter.It ranges from a high estimate of $12.6M to a low estimate of $10.7M. As of. The current estimate, Rapid Micro Biosystems Inc’s year-ago sales were $8.22MFor the next quarter, 4 analysts are estimating revenue of $8.9M. There is a high estimate of $8.9M for the next quarter, whereas the lowest estimate is $8.9M.
A total of 4 analysts have provided revenue estimates for RPID’s current fiscal year. The highest revenue estimate was $34.9M, while the lowest revenue estimate was $33M, resulting in an average revenue estimate of $33.5M. In the same quarter a year ago, actual revenue was $28.05MBased on 4 analysts’ estimates, the company’s revenue will be $39.65M in the next fiscal year. The high estimate is $40M and the low estimate is $39.3M.
